Form4insider filings, from the source

Company · CIK 0001840229 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

MiNK Therapeutics, Inc. · INKT

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $19k · 1net −$19k
$10k$10k$100k$100k$1M$1MbuyssalesJun 3Jun 3Jun 3Jun 4Jun 4Jun 4Jun 5

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 1, 2026 AForm 4 →Sep 2, 11:10 am EDTUlf WiinbergDirector1,279$10.95$14,00523,929—
Sep 1, 2026 AForm 4 →Sep 2, 10:21 am EDTJohn Bradley HolcombDirector1,233$10.95$13,5014,691—
Sep 1, 2026 AForm 4 →Sep 2, 10:20 am EDTPeter BehnerDirector1,485$10.95$16,26124,404—
Sep 1, 2026 AForm 4 →Sep 2, 10:19 am EDTBarbara RyanDirector1,622$10.95$17,76123,591—
Sep 1, 2026 AForm 4 →Sep 2, 10:16 am EDTBrian CorveseDirector1,633$10.95$17,88154,770—
Jun 4, 2026 SForm 4 →Jun 5, 6:04 pm EDTBarbara RyanDirector1,500$12.76$19,14121,969−6.39%

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.